Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Peritoneal Neoplasms × Saline Waters × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 24 Cisplatin 16 Oxaliplatin 14 Cytoreduction Surgical Procedures 14 Paclitaxel 10 Fluorouracil 8 Doxorubicin 7 Mitomycin 6 Leucovorin 6 Docetaxel 5 Neoadjuvant Therapy 4 Blood Specimen Collection 4 Surgical Procedures, Operative 3 Chemotherapy, Adjuvant 3 Bevacizumab 3 catumaxomab 2 Taxes 2 Platinum 2 Palliative Care 2 Observation 2 Nivolumab 2 Mitozytrex 2 Carboplatin 2 1,2-diaminocyclohexaneplatinum II citrate 2 tremelimumab 1 talimogene laherparepvec 1 strattice 1 soluble LAG-3 protein, human 1 sodium thiosulfate 1 poly(I).poly(c12,U) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡